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The temporal distribution and mechanism of death were
studied in a large multicenter secondary prevention trial
(Aspirin Myocardial Infarction Study) in which acute
witnessed death represented 72% (270 of 376) of the
deaths due to arteriosclerotic heart disease. Instanta-
neous deaths represented 28.9% (78 of 270) of the acute
witnessed deaths; 45.2% (122 of 270) occurred in the
first hour after the onset of symptoms and were defined
as sudden deaths. In the subsequent 23 hours, an ad-
ditional 113 deaths (41.8%) occurred and were defined
A descr iption of the timin g and mechanism of early death
occurring in patients with coronary heart disease can aid in
our understanding of the pathophysiology of this diseas e .
The recent development of a number of therapeutic inter-
ventions aimed at the prevention of both coronary heart
disease mortality and sudden death requires an understand-
ing of both of these factor s. To test these interventions, a
uniform definition of these factors is important to compare
different mode s of therapy ( I). It is also possible that certain
unique clinical characteristics exist in patient s at risk of
dying that will perm it us to dist inguish the sudden death
victim from those who will not die suddenly,
The Aspirin Myocard ial Infarction Study (AMIS) (2) pro-
vides an opportunity to examine death s occ urring in a large
seco ndary prevention trial in a systematic manner. In pre-
vious studies (3- 6) of similar groups. it has been noted that
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as intermediate deaths; 29 late deaths (10.7%) occurred
after 24 hours. Cardiac arrhythmia was the mechanism
of death in 83% (194 of 235) of deaths within 24 hours.
Univariate analysis of baseline clinical and electrocar-
diographic characteristics indicates that a history of
congestive heart failure , cardiomegaly, angina pectoris,
multiple niyocardial infarctions and therapy with digi-
talis and nitroglycerin were more common in those who
died than in survivors, regardless of the timing of death.
most of the deaths occur within the first hour of the onset
of symptoms, The mechanism of death in patients dying of
coro nary heart disease is complex and often multifactorial.
The witness to the event can often shed light on its mech-
anism, In this study, we related the timing of the event to
the observation made by the witne sses of the death to arrive
at the presumed mechanism of the event. In addition, the
past medical history availabl e in th is group provided us with
an opportunity to relate the baselin e variables. collected in
a prospecti ve manner , to the mechanism and timing of death .
Methods
Source of data. Because there was no significant dif-
ference in the mortality rate in the treated (aspirin, Ig/day)
and placebo groups of patients, all cardi ac deaths occurring
in the Aspirin Myocardial Infarction Study were included
and treated equally in the analysis . The se forms were com-
pleted by both clinical coordinators and physicians by col-
lecting information from witnesses of the event when avail-
able. The forms were in a mult iple question format , but
also provided a narrative portion in which the physician was
required to describe all the information available regarding
the fatal event. In the 4,524 patients followed up for a mean
0735-1097 /84/$3.00
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Table 1. Categories of Mortality Due to Ateriosclerotic Heart
Disease (ASHD)
of 38.2 months in this trial, 465 deaths were reported. Of
these, 376 were due to arteriosclerotic heart disease and 270
were witnessed acute events and are the subject of this report
(table 1).
The forms were reviewed by a seven member Mortality
Classification Committee that evaluated materials submitted
by each clinic physician. The data included autopsy infor-
mation, emergency vehicle and emergency room reports,
hospital records, death certificates and interviews of next
of kin and witnesses of the event. Each form was reviewed
independently by two committee members. Discrepancies
in interpretation were adjudicated in meetings of the entire
committee.
Definitions
Deaths due to arteriosclerotic heart disease. The fol-
lowing set of definitions was established before the evalu-
ation of these forms:
Arteriosclerotic heart disease death. Because all pa-
tients in this study were determined to have had a myocardial
infarction secondary to atherosclerosis at entry, further sub-
stantiation of the presence of atherosclerotic heart disease
was not required. All deaths except those due to trauma or
other definite noncardiac disease were presumed to be caused
by arteriosclerotic heart disease.
Acute arteriosclerotic heart disease death (with recent
or acute event): Individuals who either experienced new
symptoms suggesting acute myocardial infarction or isch-
emia such as chest pain or shortness of breath or who died
within minutes without symptoms or whose death was
unobserved.
Nonacute arteriosclerotic heart disease death (without
recent or acute event): Death as a progressive manifestation
of previous symptomatic coronary heart disease such as
progressive heart failure.
Primary mechanisms of death. These were judged to
be due to:
Definite cardiac arrhythmia: In patients with actual
electrocardiographic evidence of cardiac arrhythmia. When
an abnormal rhythm occurred in the setting of shock and
congestive heart failure it was excluded as a primary event.
Acute witnessed ASHD Death
Sudden death < I hour
Instantaneous
Additional < I hour
Intermediate death (I to 24 hour)
Late death (> 24 hour)
Incomplete information
Acute non-witnessed death
Nonacute ASHD death
Total
270
122
78
44
113
29
6
81
25
376
Presumed cardiac arrhythmia: In patients who died sud-
denly without evidence of cardiovascular or other symp-
toms. These events were usually instantaneous and were
presumed to be due to cardiac arrhythmia in the absence of
expression by the victim of any symptoms.
Cardiogenic shock: In patients with a blood pressure of
less than 90 mm Hg, central nervous system deterioration
and oliguria. When shock occurred after the development
of a definite cardiac arrhythmia, it was excluded as a primary
event.
Heartfailure: In patients with symptoms of shortness of
breath or orthopnea in the absence of cardiogenic shock or
definite arrhythmia. When heart failure preceded cardi-
ogenic shock or an arrhythmia it was coded as the primary
mechanism of death; otherwise it was excluded as a primary
event.
Cardiac surgery: In patients who died within 30 days
of cardiac surgery. When patients experienced a myocardial
infarction immediately before cardiac surgery, the myo-
cardial infarction was considered a contributing and under-
lying cause of death arid cardiovascular surgery was con-
sidered the primary cause.
Other definitions. The following additional terms were
used:
Acute symptoms: New symptoms or marked changes in
the chronic symptoms occurring before death. Symptoms
were defined as chronic if they continued until death without
change. In the presence of chronic symptoms, acute symp-
toms were determined to have occurred only if I) chronic
symptoms disappeared and suddenly reappeared before death;
2) stable chronic symptoms became more significant before
the event; or 3) chronic symptoms had been stable or im-
proving and significant new symptoms occurred 24 hours
before the time of death. If the patient died while asleep
and without apparent acute symptoms, the patient was con-
sidered to have died without symptoms.
Time of death: Time at which the victim was found to
be without pulse and blood pressure and unresponsive by
the witness, and before the onset of an unsuccessful car-
diopulmonary resuscitation effort. If resuscitation was suc-
cessful and the patient returned to normal function and was
discharged from the hospital, a death event was not re-
corded. The timing and onset of symptoms was established
by interviewing the witness of the event.
Hospital and out of hospital death: Death occurring in
the emergency room was classified as a hospital death, even
if the patient was not formally admitted to the hospital. If
the patient was dead on arrival, the event was classified as
an out of hospital death, even if the patient was pronounced
dead in the hospital.
Sudden death: Death occurring within I hour of the onset
of symptoms. This included instantaneous death (acute col-
lapse without any symptoms) and death occurring within
the subsequent hour after the onset of symptoms.
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Figure 1. Mechanism of death related to duration of symptoms
before death. CHF = congestive heart failure.
97 .5%
disease. During the next 23 hours, 113 deaths occurred
(intermediate deaths) and an additional 29 late deaths oc-
curred more than 24 hours after the onset of symptoms.
Mechanism of death (Fig. 1). Cardiac arrhythmia was
the dominant mechanism in 83% (194 of 235) of both the
sudden and nonsudden witnessed deaths. Of these ar-
rhythmic deaths, 40% (78 of 194) were classified as due to
definite and 60% (116 of 194) to presumed arrhythmia.
Shock and congestive heart failure occurred with increased
frequency in the nonsudden death group.
Clinical and electrocardiographic characteristics (Ta-
bles 2 to 4). Table 2 compares the baseline clinical char-
acteristics of the victims of sudden and intermediate death
and the study survivors. There were no significant differ-
ences between the sudden and intermediate death groups.
However, each of these two groups differed from the sur-
vivors by having a history of congestive heart failure, car-
diomegaly, angina pectoris, New York Heart Association
functional class II and more than one myocardial infarction.
They also were taking digitalis and more commonly used
nitroglycerin tablets.
The baseline electrocardiographic characteristics in the
study patients (Table 3), with the exception of premature
ventricular complexes, did not distinguish patients with sud-
den from those with intermediate death. ST depression, T
wave abnormalities and intraventricular conduction defects
were more common in those who died in either manner than
in survivors. Premature ventricular complexes were ob-
served more frequently in the patients who died suddenly
than in the intermediate death group and about twice as
often as in those who were alive at the end of the study
period. Comparison of instantaneous deaths with other deaths
in the first hour and with intermediate deaths, in terms of
both clinical and electrocardiographic variables, did not show
any statistically significant differences. A multiple logistic
regression analysis was also performed. Cardiomegaly,
number of previous myocardial infarctions, history of an-
gina, use of digitalis, presence of Q or QS wave abnor-
malities and premature ventricular complexes on the elec-
Intermediate death: Death occurring between I and 24
hours after the onset of acute symptoms.
Late death: Death occurring 24 or more hours after the
onset of symptoms.
Witnessed death: Death occurring in the presence of a
person who had visual or auditory contact with the victim
at the moment of death.
Results
Categories of mortality due to arteriosclerotic heart
disease (Table 1). Of all such deaths, 72% (270 of 376)
were acute and witnessed. Of these, 28.9% (78 of 270) were
instantaneous deaths occurring without any apparent symp-
toms. An additional 44 patients died within the first hour
after acute symptoms. Therefore, sudden deaths, defined
here as death within I hour, represented 45.2% (122 of 270)
of the witnessed deaths due to acute arteriosclerotic heart
Study Protocol
Data collection and analysis. For all patients, data on
a wide variety of medical, historical, social, demographic
and laboratory characteristics were available from the base-
line examination at the beginning of the study. The baseline
electrocardiogram at rest was recorded at the time of ran-
domization; it was sent to the AMIS electrocardiographic
reading center at The George Washington University Med-
ical Center where it was mounted and labeled. Each elec-
trocardiogram was coded by two specially trained techni-
cians, working independently using the Minnesota Coding
System (7). Premature beats were identified as to type and
frequency. Disagreements were resolved by one of the in-
vestigators. The readings were made without knowledge of
source, treatment group or previous electrocardiograms. Re-
ports of all autopsies were collected. They were not per-
formed using a standard protocol, Gross and microscopic
reports were reviewed and classification of postmortem find-
ings was established by the Mortality Classification
Committee.
Statistical analysis. Analysis of this information on study
patients was carried out in cooperation with the study co-
ordinating center at the University of Maryland, and the
Clinical Trials and Mathematical and Applied Statistics
Branches of the National Heart, Lung, and Blood Institute.
Differences between groups were assessed by the Student's
t test for continuous variables and by the continuity corrected
chi-square for discrete factors. The joint evaluation of risk
factors for sudden and intermediate death was evaluated by
multiple logistic regression analyses. The coefficients for
these analyses were estimated by the method of weighted
least squares (8). Because of the considerable number of
nonindependent comparisons, we have noted only those dif-
ferences with probability (p) values less than 0.01.
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Table 2. Clinical Characteristics at Baseline of All Aspirin Myocardial Infarction Study
Survivors and 235 With a Witnessed Death Due to Arteriosclerotic Heart Disease Within 24
Hours of Symptoms
Sudden Death Intermediate Death
< I hour (%) I to 24 hour (%) Alive (%)
(n = 122) (n = 113) (n = 4,059)
Mean age (yr) 55.2 54.9 54.6
Male 94.3 92.9 88.4
White 88.5 88.5 92.1
Black 7.4 9.7 5.5
Hypertensiont 18.0 17.7 13.4
Congestive heart failure 20.5* 25.7* 8.6
Cardiomegaly on X-ray film 23.8* 25.7* 7.4
NYHA class II 48.4* 46.9* 31.5
Angina pectoris 45.1 * 46.9* 30.2
More than one myocardial 25.4* 23.0* 10.4
infarction
Current cigarette smokers 28.7 32.7 26.3
Never smoked 18.0 23.0 19.8
Medical therapy at baseline
Digitalis 36.9* 35.4* 15.6
Propranolol 10.7 13.3 12.0
Antiarrhythmic agents 13.9 14.2 9.1
Nitroglycerin 50.8* 50.4* 36.3
*p < 0.01 (sudden and intermediate death vs. alive); thypertension = systolic pressure 140 mm Hg and
diastolic pressure 80mm Hg. Congestive heart failure, NYHA functional class and angina pectoris determined
byclinic physician. NYHA = New York Heart Association.
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trocardiogram were significantly related to sudden death
(Table 4). Similar analyses for intermediate deaths showed
that all of these factors except premature beats and Q or QS
wave abnormalities were related to deaths occurring I to 24
hours after the onset of symptoms.
Acute symptoms and classification of death (Table
5). Chest pain and symptoms in general were more common
(p < 0.01) in the intermediate than in the sudden death
group. This is due in a large part to the many patients in
the sudden death group who died instantaneously and who,
therefore, by definition, had no acute symptoms. The oc-
currence of other symptoms was the same for both groups.
Place of death and activity at time of death (Table
6). There was a significant difference in the distribution of
type of activities at the time of death and in the place of
death of the intermediate and sudden death groups
(p < 0.01). Proportionately more people were asleep or
engaged in sedentary activities at the time of onset of acute
symptoms in the intermediate death group than in the sudden
death group. As would be expected, most of the witnessed
sudden deaths occurred at home, whereas more than half
of the witnessed intermediate deaths occurred in the hos-
pital. Of the patients in the intermediate death group who
died at home, 66% had chest discomfort (Table 7).
Postmortem examinations (Table 8). These were
available in 50 individuals (18.5%) whose witnessed death
Table 3. Electrocardiographic Characteristics at Baseline of All Study Survivors and the 235
Patients Who Died Within 24 Hours of Symptoms
Sudden Death Intermediate Death
< I hour (%) I to 24 hours (%) Alive (%)
(n = 122) (n = 113) (n = 4,059)
STdepression 40.4* 45.0* 23.6
T wave abnormalities 81.7* 80.0* 66.4
STelevation 26.8 19.6 18.6
AV conduction abnormalities 5.0 2.7 3.0
Intraventricular conduction [3.2* 11.6* 3.4
abnormalities
Q/QS pattern 90.0 870 80.2
Premature ventricular complexes 30.5t 19.6 14.6
*p < 0.01 (sudden and intermediate death versus alive); tp < 0.01 (sudden death versus alive). AV =
atrioventricular.
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Table 4. Logistic Regression Coefficients for Sudden and
Intermediate Deaths
Table 6. Place of Death and Activity of Subjects With
Witnessed Deaths Occurring in Less Than 24 Hours
Sudden
Death
< I hour
Intermediate
Death
I to 24 hours
Sudden Death
< I hour (%)
(n = 122)
Intermediate Death
1 to 24 hours (%)
(n = 113)
Table 5. Presence and Nature of Symptoms in Witnessed
Deaths Occurring in Less Than 24 Hours
occurred in less than 24 hours from the onset of symptoms.
Evidence of an acute myocardial infarction was seen in 35%
of the postmortem examinations in the sudden death group.
There were substantiallymore cases of left ventricular aneu-
rysm and recent myocardial infarction in the intermediate
than in the sudden death group, but these differences did
not reach statistical significancein light of the small number
of autopsies performed.
Discussion
The fact that most cardiac deaths occur suddenly with
little warning has been the subject of renewed interest as
new therapeutic interventions have become available. The
temporal distribution of deaths observed in this study is
similar to that of previous observations (3,4) and indicates
that the case fatality rate is extremely high in the first hour
of the onset of symptoms and decreases over the subsequent
24 hours. Most sudden deaths (64%) in this study were
instantaneous, occurring without symptoms. Of the acute
witnessed deaths in this study, 45% occurred within the first
hour, similar to the experience reported by Hinkle and Thaler
(6). Only 12% of the sudden deaths occurred in the hospital,
50% occurred at home. Many patients also have acute symp-
*p < 0.05; tp < 0.01.
66
42
26
5
II
o
II
24
Home (%)
(n = 38)
19.5
61.1
8.8
2.7
7.9
33.6
4.4
53.2
8.8
77
45
17
10
10
8
5
20
Hospital (%)*
(n = 60)
8.2
42.6
30.3
12.3
6.6
50.0
25.4
12.3
12.3
Chest pain
Shortness ofbreath
Fatigue
Indigestion/abdominal pain
Syncope
Palpitation
Dizziness
Other
Place*
home
Public place
Hospital
Other
Activity*
Asleep
Sedentary
Light work
Moderate work
Unknown
Table 7. The Nature of Symptoms Before Intermediate Death
(I to 24 hours) Related to Place of Death
*p < 0.01 represents adifference in distribution characteristics between
the sudden and intermediate deaths.
toms for more than I hour and die at home, outside the
perimeters of medical or medical emergency care.
Roles of arrhythmia, cardiac failure, myocardial in-
farction and ischemia. The primacy of rhythm disturbance
as a mechanism of cardiac death in the first 24 hours is also
emphasized in this study. Although we cannot provide in-
formation regarding the relation of preexisting ischemia to
rhythm disturbances, it is clear that cardiac arrhythmia is a
primary clinical mechanism and the dominant mechanism
of death in the first 24 hours. When cardiac failure mani-
fested by congestive heart failure and shock does occur, it
is a relatively late event and even then represents an unusual
mechanismof cardiac death in this time frame. It is probable
that ischemia or infarction, or both, often precedes both the
arrhythmia and events due to left ventricular dysfunction.
In previous studies (9) of patients who were resuscitated
after out of hospital cardiac arrest due to arteriosclerotic
heart disease, 78% of patients were observed to have either
infarction or ischemia. In our study, postmortem evidence
of myocardial infarction was observed in 35% of the sudden
deaths and 75% of the nonsudden deaths in the small pro-
portion of patients undergoing autopsy. Using a similar def-
1.0m
0.698t
0.547*
0.220t
0.498*
0.062
0.127
49.6
15.0
25.7
10.6
1.8
5.3
5.3
12.4
4.4
Intermediate Death
I to 24 hours (%)
(n = 113)
0.926t
0.646t
0.583t
0.142*
0.470*
0.510t
0.246*
18.0*
14.8
12.3
5.7
2.5
1.6
3.3
4.1
3.3
Sudden Death
< I hour (%)
(n = 122)
Chest pain
Fatigue
Shortness ofbreath
Abdominal pain
Palpitation
Syncope
Dizziness
Apprehension
Depression
Cardiomegaly on X-ray film
Number of prior myocardial infarctions
Use of digitalis
ST depression
Angina pectoris
Premature ventricular complexes
Q/QS pattern
*p < 0.01 (sudden death versus intermediate death). *Data from one person are missing.
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*n = the number of patients who had postmortem examination.
Table 8. Significant Postmortem Cardiovascular Abnormalities
in Witnessed Deaths Occurring in Less Than 24 Hours
inition, Hinkle and Thaler (6), in a long-term follow-up
study of individuals with mixed cardiovascular disease, ob-
served that cardiac arrhythmia was the predominant feature
in acute cardiac deaths. In that study, myocardial infarction
and ischemia were observed at postmortem in 33% of the
patient group. Although evidence of myocardial infarction
was not detected by histologic techniques in 65% of the
patients dying suddenly in that study, this does not indicate
that microscopic evidence of ischemia did not precede the
development of sudden cardiac arrhythmia. The pathologic
evidence of myocardial infarction requires patient viability
and survival for a period of time before the currently avail-
able pathologic characteristics of myocardial infarction can
develop.
Premature ventricular complexes in prediction ofsud-
den death. A number of studies (10-13) have attempted
to identify certain characteristics that will predict sudden
cardiac death. In previous studies, those characteristics that
predicted sudden cardiac mortality also predicted all coro-
nary deaths. Chiang et al. (10) observed that premature
ventricular complexes and conduction abnormalities were
frequently noted on the standard electrocardiogram in vic-
tims of sudden death in the Tecumseh study. Inthe Coronary
Drug Project (14), premature ventricular complexes re-
corded on a standard electrocardiogram were predictive of
both sudden death and death from all causes. Statistical
analysis in that study suggested that premature ventricular
complexes were uniquely associated with sudden death and
were independent of other electrocardiographic or clinical
characteristics. Over the 3 year follow-up of the Coronary
Drug Project study, the mortality rate in the patients with
premature ventricular complexes was twice that of the pa-
tients without such complexes. In a postcoronary care unit
group, Moss et al. (15) studied comorbidity factors predic-
tive of sudden and nonsudden death. The factors studied
included premature ventricular complex frequency and clin-
ical· evidence of left ventricular dysfunction. They were
unable to identify any features unique to the sudden death
group. In contrast, Ruberman et al. (13) observed that pre-
Recent myocardial infarction
Left ventricular aneurysm
Recent coronary artery
occlusion by thrombus or
embolus
Recent coronary artery
occlusion by hemorrhage
Pulmonary edema
Sudden Death
< I hour (0/0)
(*n = 22)
35
10
30
5
60
Intermediate Death
I to 24 hours
(n = 28)
75
32
54
14
82
mature ventricular complex frequency and complexity ob-
served on a I hour electrocardiographic recording provide
information on postmyocardial infarction patients to predict
sudden death independently of clinical evidence of left ven-
tricular dysfunction. In our study, premature ventricular
complexes present on a single baseline electrocardiogram
were more frequent in the patients who died suddenly than
in those who died I to 24 hours after the onset of symptoms
and the survivors of the study.
Implications. Our observations support the fact that most
deaths from coronary heart disease occur within the first
few hours of symptoms. With the exception of premature
ventricular complexes, there were no obvious predictors of
sudden rather than intermediate death. Within the first 24
hours, and particularly the first hour, rhythm disturbances
were the most common mechanism of death. Whether these
rhythm disturbances were primary or secondary to acute
ischemia requires further investigation.
APPENDIX
Aspirin Myocardial Infarction Study (AMIS):
Principal Investigators
Pantel S. Vokonas, MD, Boston City Hospital, Boston,
Massachusetts; Stephen Scheidt, MD, Cornell University
Medical Center, New York, New York; Robert C. Schlant,
MD, Emory University, Atlanta, Georgia; Gary N. Wilner,
MD, Evanston Hospital, Evanston, Illinois; Charles A. Lau-
bach, Jr., MD, Geisinger Medical Center, Danville, Penn-
sylvania; Thaddeus E. Prout, MD, Greater Baltimore Med-
ical Center, Baltimore, Maryland; Peter T. Kuo, MD, Heart
Clinic, Raritan Valley Hospital, Rutgers Medical School,
Piscataway, New Jersey; Sidney Goldstein, MD, Henry Ford
Hospital, Detroit, Michigan; William L. Holmes, MD, Lan-
kenau Hospital, Philadelphia, Pennsylvania; Paul Samuel,
MD, Long Island Jewish-Hillside Medical Center, New Hyde
Park, New York; David W. Richardson, MD, Medical Col-
lege of Virginia, Richmond, Virginia; Marvin Segal, MD,
Mount Sinai Hospital, Minneapolis, Minnesota; William H.
Bernstein, MD, Mount Sinai Medical Center, Miami Beach,
Florida; Olga Haring, MD, Northwestern University, Chi-
cago, Illinois; C. Basil Williams, MD, Ogden Research
Foundation, Ogden, Utah; J. Judson McNamara, MD, Pa-
cific Health Research Institute, Honolulu, Hawaii; Bernard
1. Lewis, MD, Palo Alto Medical Center and Research
Foundation, Palo Alto, California; James A. Schoenberger,
MD (Chairman, Steering Committee), Rush Presbyterian-
St. Lukes Medical Center, Chicago, Illinois; David M.
Berkson, MD, Saint Joseph Hospital, Chicago, Illinois; Al-
lan H. Barker, MD, Salt Lake City Research Foundation,
Salt Lake City, Utah; Elmer E. Cooper, MD, Santa Rosa
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Medical Center Clinic, San Antonio, Texas; Nemat O. Bor-
hani, MD, University of California at Davis, Davis, Cali-
fornia; Noble O. Fowler, MD, University of Cincinnati
Medical Center, Cincinnati, Ohio; Henry K. Schoch, MD,
University of Michigan, Ann Arbor, Michigan; Richard G.
Hutchinson, MD, University of Mississippi Medical Center,
Jackson, Mississippi; Mario R. Garcia-Palmieri, University
of Puerto Rico, San Juan, Puerto Rico; Jessie Marmorston,
MD, University of Southern California, Los Angeles, Cal-
ifornia; J. Joanne Hoover, MD, University of Washington,
Seattle, Washington; Philip H. Frost, MD, USPHS Hos-
pital, San Francisco, California; Hugh R. Gilmore Ill, MD,
Veterans Administration Hospital, Miami, Florida; William
T. Friedewald, MD, National Heart, Lung, and Blood In-
stitute, Bethesda, Maryland; Dayton T. Miller, PhD, Cen-
tral Laboratory, Center for Disease Control, Atlanta, Geor-
gia; Jorge C. Rios, MD, ECG Reading Center, George
Washington University, Washington, D.C.; William F. Krol,
PhD, Coordinating Center, University of Maryland, Balti-
more, Maryland; Lawrence Friedman, MD, National Heart,
Lung, and Blood Institute, Project Office, Bethesda,
Maryland.
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